Vasoactive Intestinal Peptide Promising Treatment for COVID-19 Respiratory Failure
Use of vasoactive intestinal peptide to treat critical COVID-19 respiratory failure in patients with comorbidities has shown promise.
All articles by Sheila Jacobs
COPD Case-Finding Tool Validated, Ready for Use in Primary Care
Use of the COPD case-finding tool, CAPTURE, in US primary care practice demonstrated ability to provide critical in-study information to help guide protocol adjustment based on unforeseen events and to clearly outline COPD diagnostic processes.
Asthma, COPD Disease Severity May Increase Risk of Developing Severe COVID-19
Disease severity of both chronic obstructive pulmonary disease (COPD) and asthma may increase the risk of the development of severe coronavirus disease 2019 (COVID-19).
Asthma Associated With Comparable Risk of Hospitalization in COVID-19
Compared with the absence of asthma, the presence of asthma is associated with a comparable risk of hospitalization and use of mechanical ventilation, and a lower risk of mortality in patients with COVID-19.
Electronic Medication Monitors May Improve Inhaler Adherence in Asthma
In patients with asthma, the use of inhaler electronic medication monitors with both rescue and controller inhalers is associated with higher adherence to these devices.
Benralizumab Achieves Clinically Meaningful Improvements in Asthma, Nasal Polyposis
The majority of patients with asthma and nasal polyposis who were treated with benralizumab were considered “comprehensive responders.”
Secondary Spontaneous Pneumothorax Incidence in COPD, Emphysema
The incidence and prevalence of a first-ever spontaneous pneumothorax in patients with chronic obstructive pulmonary disease (COPD) and emphysema are increased significantly in men and in Black patients.
Oral Sustained-Release Morphine May Improve Moderate, Severe Breathlessness in COPD
The use of regular, low-dose, oral sustained-release morphine for 4 weeks in patients with COPD and moderate to very severe breathlessness has been shown to improve disease-specific health status.
Differences in Anxiety, Depression According to Current and Former Smoking Status
Both stable current smokers and individuals who had quit exhibited significantly less anxiety but more depression.
COPD Maintenance Therapy: Adverse Outcomes With Tiotropium/Olodaterol vs LABA/ICS
In patients with COPD, tiotropium/olodaterol was associated with a lower risk for escalation to triple therapy or the development of adverse outcomes compared with LABA/ICS.
